AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
99 hedge funds and large institutions have $79.5M invested in AVEO Pharmaceuticals, Inc. in 2018 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 30 increasing their positions, 24 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
52% less capital invested
Capital invested by funds: $166M → $79.5M (-$86.4M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
99
Holding in Top 10
–
Calls
$12.3M
Puts
$3.63M
Top Buyers
| 1 | +$3.73M | |
| 2 | +$3.52M | |
| 3 | +$594K | |
| 4 |
SC
Sculptor Capital
New York
|
+$580K |
| 5 |
D.E. Shaw & Co
New York
|
+$455K |
Top Sellers
| 1 | -$13.6M | |
| 2 | -$1.84M | |
| 3 | -$1.32M | |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$1.16M |
| 5 |
6CM
683 Capital Management
New York
|
-$920K |